• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卵巢癌的流行病学

The epidemiology of ovarian cancer.

作者信息

Tortolero-Luna G, Mitchell M F

机构信息

Department of Gynecologic Oncology, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA.

出版信息

J Cell Biochem Suppl. 1995;23:200-7. doi: 10.1002/jcb.240590927.

DOI:10.1002/jcb.240590927
PMID:8747397
Abstract

Ovarian cancer is the second most common cancer of the female reproductive system and the leading cause of death from gynecologic malignancies. In 1995, 26,600 women will be diagnosed with ovarian cancer in the U.S., and 14,500 women will die from the disease. Between 1986-1900, the overall age-adjusted incidence was 14.3/100,000 women; mortality was 7.8/100,000 women. Ovarian cancer, rare before age 40, increases steeply thereafter and peaks at ages 65-75. Incidence and mortality rates are higher among white women than among African-American women. Over the last three decades, ovarian cancer incidence has remained stable in high-risk countries, while an increasing trend has been reported in low-risk countries. Despite recent advancements in treatment, the overall five-year survival rates continues to be low (39%). Over 70% of ovarian tumors are diagnosed when regional or distant involvement has already occurred, causing survival rates to remain stable. The etiology of ovarian cancer is poorly understood. Most studies have focused on the epidemiology of invasive epithelial ovarian tumors, while few have explored the epidemiology of epithelial tumors of low malignant potential and nonepithelial tumors. Factors associated with an increased risk for invasive epithelial ovarian cancer include age, race, nulliparity, family history of ovarian cancer, and history of endometrial or breast cancer. Factors associated with a reduced risk are history of one or more full-term pregnancies, use of oral contraceptives, history of breast feeding, tubal ligation, and hysterectomy. Other factors such as infertility drugs, hormone replacement therapy, age at menarche, age at menopause, dietary factors, lactose intolerance, talc use, coffee and alcohol consumption have been suggested, but their role is still inconclusive.

摘要

卵巢癌是女性生殖系统中第二常见的癌症,也是妇科恶性肿瘤的主要死因。1995年,美国将有26,600名女性被诊断出患有卵巢癌,14,500名女性将死于该疾病。1986年至1990年期间,总体年龄调整发病率为每10万名女性中有14.3例;死亡率为每10万名女性中有7.8例。卵巢癌在40岁之前很少见,此后急剧增加,并在65至75岁达到峰值。白人女性的发病率和死亡率高于非裔美国女性。在过去三十年中,高风险国家的卵巢癌发病率保持稳定,而低风险国家则报告有上升趋势。尽管最近治疗有所进展,但总体五年生存率仍然很低(39%)。超过70%的卵巢肿瘤在已经发生局部或远处转移时才被诊断出来,导致生存率保持稳定。卵巢癌的病因尚不清楚。大多数研究集中在侵袭性上皮性卵巢肿瘤的流行病学,而很少有人探讨低恶性潜能上皮性肿瘤和非上皮性肿瘤的流行病学。与侵袭性上皮性卵巢癌风险增加相关的因素包括年龄、种族、未生育、卵巢癌家族史以及子宫内膜癌或乳腺癌病史。与风险降低相关的因素是一次或多次足月妊娠史、口服避孕药的使用、母乳喂养史、输卵管结扎和子宫切除术。还提出了其他因素,如不孕药物、激素替代疗法、初潮年龄、绝经年龄、饮食因素、乳糖不耐受、滑石粉使用、咖啡和酒精消费,但它们的作用仍不确定。

相似文献

1
The epidemiology of ovarian cancer.卵巢癌的流行病学
J Cell Biochem Suppl. 1995;23:200-7. doi: 10.1002/jcb.240590927.
2
Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.预防性卵巢切除术:降低美国上皮性卵巢癌死亡率。一场持续的争论。
Oncologist. 1996;1(5):326-330.
3
Hormonal aspects of epithelial ovarian cancer: review of epidemiological evidence.上皮性卵巢癌的激素方面:流行病学证据综述
Clin Endocrinol (Oxf). 1998 Dec;49(6):695-707. doi: 10.1046/j.1365-2265.1998.00577.x.
4
The epidemiology of ovarian cancer in Greece: a case-control study.希腊卵巢癌的流行病学:一项病例对照研究。
Eur J Cancer Clin Oncol. 1984 Aug;20(8):1045-52. doi: 10.1016/0277-5379(84)90107-x.
5
Personal and environmental characteristics related to epithelial ovarian cancer. II. Exposures to talcum powder, tobacco, alcohol, and coffee.与上皮性卵巢癌相关的个人及环境特征。II. 滑石粉、烟草、酒精及咖啡暴露情况。
Am J Epidemiol. 1988 Dec;128(6):1228-40. doi: 10.1093/oxfordjournals.aje.a115077.
6
Epidemiology of ovarian cancer.卵巢癌流行病学
Methods Mol Biol. 2009;472:413-37. doi: 10.1007/978-1-60327-492-0_20.
7
Epidemiology of ovarian cancer: a summary review.卵巢癌流行病学:综述
Eur J Cancer Prev. 2001 Apr;10(2):125-9. doi: 10.1097/00008469-200104000-00002.
8
Worldwide variations in the lifetime probability of reproductive cancer in women: implications of best-case, worst-case, and likely-case assumptions about the effect of oral contraceptive use.全球女性生殖系统癌症终生发病概率的差异:关于口服避孕药使用效果的最佳情况、最差情况及可能情况假设的影响
Contraception. 1992 Feb;45(2):93-104. doi: 10.1016/0010-7824(92)90043-s.
9
Risk factors for ovarian cancer: a case-control study.卵巢癌的危险因素:一项病例对照研究。
Br J Cancer. 1989 Oct;60(4):592-8. doi: 10.1038/bjc.1989.320.
10
Ovarian and endometrial cancers.卵巢癌和子宫内膜癌。
Cancer Surv. 1994;19-20:287-307.

引用本文的文献

1
Deregulated Metabolic Pathways in Ovarian Cancer: Cause and Consequence.卵巢癌中代谢途径失调:原因与后果
Metabolites. 2023 Apr 15;13(4):560. doi: 10.3390/metabo13040560.
2
Layer-by-layer nanoparticles for novel delivery of cisplatin and PARP inhibitors for platinum-based drug resistance therapy in ovarian cancer.用于顺铂和PARP抑制剂新型递送的层层组装纳米颗粒,用于卵巢癌铂类耐药治疗
Bioeng Transl Med. 2019 Jun 14;4(2):e10131. doi: 10.1002/btm2.10131. eCollection 2019 May.
3
Tc-Glucarate for assessment of paclitaxel therapy in human ovarian cancer in mice.
用于评估紫杉醇对小鼠人卵巢癌治疗效果的葡萄糖醛酸锝
Iran J Basic Med Sci. 2018 Jan;21(1):77-82. doi: 10.22038/IJBMS.2017.24707.6138.
4
Functional Constraints on Replacing an Essential Gene with Its Ancient and Modern Homologs.用其古代和现代同源基因替换必需基因的功能限制。
mBio. 2017 Aug 29;8(4):e01276-17. doi: 10.1128/mBio.01276-17.
5
Follicle Depletion Provides a Permissive Environment for Ovarian Carcinogenesis.卵泡耗竭为卵巢癌发生提供了有利环境。
Mol Cell Biol. 2016 Aug 26;36(18):2418-30. doi: 10.1128/MCB.00202-16. Print 2016 Sep 15.
6
Histone deacetylases as new therapy targets for platinum-resistant epithelial ovarian cancer.组蛋白去乙酰化酶作为铂耐药上皮性卵巢癌的新治疗靶点
J Cancer Res Clin Oncol. 2016 Aug;142(8):1659-71. doi: 10.1007/s00432-015-2064-5. Epub 2015 Nov 11.
7
Evidence of differential effects of vitamin d receptor variants on epithelial ovarian cancer risk by predicted vitamin d status.维生素D受体变异体对上皮性卵巢癌风险的差异影响的证据,基于预测的维生素D状态。
Front Oncol. 2014 Oct 20;4:286. doi: 10.3389/fonc.2014.00286. eCollection 2014.
8
Clinical epidemiology of epithelial ovarian cancer in the UK.英国上皮性卵巢癌的临床流行病学
Int J Womens Health. 2014 May 23;6:537-45. doi: 10.2147/IJWH.S40894. eCollection 2014.
9
Recent concepts of ovarian carcinogenesis: type I and type II.卵巢癌发生的最新概念:I型和II型。
Biomed Res Int. 2014;2014:934261. doi: 10.1155/2014/934261. Epub 2014 Apr 23.
10
Development of a mouse model of menopausal ovarian cancer.绝经后卵巢癌小鼠模型的建立
Front Oncol. 2014 Feb 26;4:36. doi: 10.3389/fonc.2014.00036. eCollection 2014.